This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry...
Pharmaceutical company AbbVie should announce its next annual dividend increase in October. The company has increased its dividend each year since its spin-off from...
From my experience, some of the best investment opportunities involve companies that are experiencing pain. During difficult times, the market can inflict more pain...
Investment Thesis I covered Zscaler, Inc. (NASDAQ:ZS) earlier in July, in which I covered ZS’s competitive position in the market. In this article, I...